Taiyen Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Taiyen Biotech has a total shareholder equity of NT$6.5B and total debt of NT$187.8M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are NT$8.3B and NT$1.8B respectively. Taiyen Biotech's EBIT is NT$321.4M making its interest coverage ratio -9.9. It has cash and short-term investments of NT$1.8B.
Key information
2.9%
Debt to equity ratio
NT$187.82m
Debt
| Interest coverage ratio | -9.9x |
| Cash | NT$1.84b |
| Equity | NT$6.55b |
| Total liabilities | NT$1.77b |
| Total assets | NT$8.32b |
Recent financial health updates
Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet
Apr 24
Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly
Jan 17
Recent updates
Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet
Apr 24Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher
Apr 09A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Mar 25Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?
Mar 12Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?
Feb 14Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend
Feb 01Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)
Jan 04A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Dec 22How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?
Dec 09Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return
Nov 24Financial Position Analysis
Short Term Liabilities: 1737's short term assets (NT$3.0B) exceed its short term liabilities (NT$1.1B).
Long Term Liabilities: 1737's short term assets (NT$3.0B) exceed its long term liabilities (NT$669.9M).
Debt to Equity History and Analysis
Debt Level: 1737 has more cash than its total debt.
Reducing Debt: 1737's debt to equity ratio has increased from 0% to 2.9% over the past 5 years.
Debt Coverage: 1737's debt is well covered by operating cash flow (242%).
Interest Coverage: 1737 earns more interest than it pays, so coverage of interest payments is not a concern.